Open AccessNew Frameworks to Assess Value of Cancer Care: Strengths and Limitations
Author(s) -
Schnipper Lowell E.,
Bastian Alex
Publication year - 2016
Publication title -
the oncologist
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.176
H-Index - 164
eISSN - 1549-490X
pISSN - 1083-7159
DOI - 10.1634/theoncologist.2016-0177
Subject(s) - medicine , cancer drugs , value (mathematics) , cancer , cancer treatment , cost–benefit analysis , intensive care medicine , actuarial science , ecology , machine learning , computer science , biology , business
Confronted with the different clinical impacts of different treatments, the rising cost of cancer care, and the financial burden of high drug prices, several influential professional organizations have developed models with which to assess the clinical benefit and value of cancer treatment regimens. The goal is a system of valuing patient therapies that is aligned with the beneficial impact to the patient and society and that moves away from a fixed cost regardless of clinical circumstances.